We help transform discoveries into therapeutics
The Cascadia Drug Development Group was founded by seasoned industry experts who are passionate about immunology and drug development. CDDG provides strategic advisory support, including indication prioritization and investment opportunity diligence, as well as planning and tactical oversight of therapeutic development activities. Importantly, we help integrate quality decisions into programs early and focus on efficiently bridging the gap between discovery, lead generation and initial clinical proof of concept. By offering a flexible and virtual structure and leveraging an externalized research model, we easily adapt to client and project needs to reduce overall costs. Our aspiration is to provide the highest quality approach to drug development that maximizes the value of excellent therapeutic opportunities around the globe.
Our new report on the autoimmune disease landscape is now available!
CDDG has released a new report to help make sense of this rapidly evolving space. We provide a scientific overview of autoimmunity and dive into emerging therapeutic approaches, the major players and what we view as key factors for success. Use this form to request your free copy.
Upcoming conferences CDDG members will be attending
Reach out if you’d like to connect
CDDG offers a wide range of consulting support
〰️Immunologic disease
〰️Biologics
〰️Small molecules
〰️Biomarkers
〰️Indication selection
〰️Diligence support
〰️CRO coordination
〰️Target rationale
〰️Immunologic disease 〰️Biologics 〰️Small molecules 〰️Biomarkers 〰️Indication selection 〰️Diligence support 〰️CRO coordination 〰️Target rationale
CDDG provides both strategic guidance and access to a full range of drug development expertise. For example, we can assist with due diligence, pipeline and indication strategy or other strategic needs. We also provide hands-on guidance or direct oversight of your early stage projects to advance them efficiently and with industrial rigor. We have a strong scientific background in immunology, including drug development for immunologic disease and the integration of immunologic considerations into drug development. We support a number of therapeutic areas, including inflammatory and autoimmune disease, infectious disease and oncology. We’ve established working relationships with several research service providers and through our network of Affiliates, CDDG offers broad subject matter expertise in such areas as protein engineering, toxicology, bioanalytics, PKDM, bioinformatics and regulatory support. We can also help map plans to the clinic and help clients prepare for regulatory submissions and interactions. Importantly, all CDDG experts bring considerable hands-on industry experience and are adept at supporting a variety of projects.
Some of our specific areas of expertise
Below are areas we can help with. If you don't see what you're looking for, just ask. We’ve worked on literally dozens of targets, particularly for immunology. We have an extensive network of outside experts and strategic partners and can usually find what you need. A key advantage of our approach is that all support is coordinated within the CDDG framework, thereby improving communication efficiency and enabling more opportunities for synergy.
